The success of innovative therapies increasingly depends on the ability to create scientific, clinical, economic, and societal value for stakeholders with fundamentally different evaluation criteria. As a result, commercial operations, market access, and healthcare engagement operate at the intersection of evidence generation, health policy, reimbursement, clinical practice, and strategic positioning.